Collaboration and Strategic Alliances (Details) - License - USD ($) $ in Millions |
1 Months Ended | 3 Months Ended | ||
|---|---|---|---|---|
Apr. 30, 2025 |
Oct. 31, 2024 |
Mar. 31, 2026 |
Jun. 30, 2026 |
|
| Novo Nordisk | ||||
| Proceeds from collaborators | $ 45 | |||
| Variable consideration, regulatory milestones | $ 465 | |||
| Variable consideration, sales milestones | 475 | |||
| Novo Nordisk | First and Second Novo Nordisk Development Milestones | ||||
| Proceeds from collaborators | $ 20 | |||
| Viatris Inc. | ||||
| Proceeds from collaborators | $ 25 | |||
| Variable consideration, regulatory milestones | 12 | |||
| Variable consideration, sales milestones | $ 185 | |||